Broadrick Dale's Form 4 filing
BioRestorative Therapies, Inc. (BRTX) · filed Mar 3, 2023
- Accession no.
- 0001567619-23-004348
- Filed
- Mar 3, 2023
- Trade date
- Nov 30, 2022-Feb 22, 2023
- Filing delay
- 93 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $17.7K. It was filed 93 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Broadrick DaleCIK 0001677513 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | Common Stock | PPurchaseAcquired | +100 | $2.78 | +$278 | 298,973 | Direct | |
| Nov 30, 2022 | Common Stock | PPurchaseAcquired | +100 | $2.77 | +$277 | 299,073 | Direct | |
| Feb 22, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $2.84 | +$14,200 | 304,073 | Direct | |
| Feb 22, 2023 | Common Stock | PPurchaseAcquired | +1,000 | $2.95 | +$2,950 | 305,073 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.